Belpointe Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Buy |
5,048
+2,747
| +119% | +$295K | 0.02% | 550 |
|
|
2025
Q1 | $232K | Sell |
2,301
-5,305
| -70% | -$535K | 0.01% | 804 |
|
|
2024
Q4 | $622K | Sell |
7,606
-746
| -9% | -$61K | 0.04% | 456 |
|
|
2024
Q3 | $700K | Buy |
+8,352
| New | +$700K | 0.04% | 407 |
|
|
2024
Q2 | – | Sell |
-4,485
| Closed | -$307K | – | 859 |
|
|
2024
Q1 | $307K | Buy |
+4,485
| New | +$307K | 0.02% | 581 |
|
|
2023
Q2 | – | Sell |
-6,357
| Closed | -$318K | – | 953 |
|
|
2023
Q1 | $318K | Buy |
6,357
+627
| +11% | +$31.4K | 0.02% | 721 |
|
|
2022
Q4 | $265K | Buy |
5,730
+457
| +9% | +$21.1K | 0.02% | 766 |
|
|
2022
Q3 | $204K | Buy |
5,273
+1,965
| +59% | +$76K | 0.01% | 829 |
|
|
2022
Q2 | $123K | Sell |
3,308
-764
| -19% | -$28.4K | 0.01% | 1020 |
|
|
2022
Q1 | $181K | Sell |
4,072
-3,211
| -44% | -$143K | 0.01% | 953 |
|
|
2021
Q4 | $309K | Sell |
7,283
-84
| -1% | -$3.56K | 0.02% | 694 |
|
|
2021
Q3 | $320K | Sell |
7,367
-104
| -1% | -$4.52K | 0.02% | 658 |
|
|
2021
Q2 | $319K | Buy |
+7,471
| New | +$319K | 0.02% | 650 |
|